41
TITLE: Time to harmonize Dengue nomenclature and classification
AUTHORS: Cuypers, L; Libin, PJK; Simmonds, P; Nowe, A; Munoz Jordan, JL; Alcantara, LCJ; Vandamme, A; Santiago, GA; Theys, K;
PUBLISHED: 2017, SOURCE: TROPICAL MEDICINE & INTERNATIONAL HEALTH, VOLUME: 22
INDEXED IN: WOS
IN MY: ORCID
42
TITLE: Interactively exploring the global Dengue phylogeny with PhyloGeoTool  Full Text
AUTHORS: Libin, PJK; Vanden Eynden, E; Incardona, F; Nowe, A; Bezenchek, A; Sonnerborg, A; Vandamme, A; Theys, K; Baele, G;
PUBLISHED: 2017, SOURCE: TROPICAL MEDICINE & INTERNATIONAL HEALTH, VOLUME: 22
INDEXED IN: WOS
IN MY: ORCID
43
TITLE: The epidemic emergence of HIV: what novel enabling factors were involved?
AUTHORS: Sousa, JD; Muller, V; Vandamme, AM;
PUBLISHED: 2017, SOURCE: FUTURE VIROLOGY, VOLUME: 12, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 7
IN MY: ORCID
44
TITLE: PhyloGeoTool: interactively exploring large phylogenies in an epidemiological context
AUTHORS: Libin, P; Eynden, EV; Incardona, F; Nowe, A; Bezenchek, A; Sonnerborg, A; Vandamme, AM; Theys, K; Baele, G;
PUBLISHED: 2017, SOURCE: BIOINFORMATICS, VOLUME: 33, ISSUE: 24
INDEXED IN: WOS CrossRef: 17
IN MY: ORCID
45
TITLE: Phylogenetic evidence for underreporting of male-to-male sex among human immunodeficiency virus-infected donors in the Netherlands and Flanders
AUTHORS: van de Laar, TJ; Bezemer, D; van Laethem, K; Vandewalle, G; de Smet, A; van Wijngaerden, E; Claas, EC; van Sighem, AI; Vandamme, AM; Compernolle, V; Zaaijer, HL;
PUBLISHED: 2017, SOURCE: TRANSFUSION, VOLUME: 57, ISSUE: 5
INDEXED IN: WOS CrossRef: 12
IN MY: ORCID
46
TITLE: Quantifying Next Generation Sequencing Sample Pre-Processing Bias in HIV-1 Complete Genome Sequencing  Full Text
AUTHORS: Bram Vrancken; Nidia Sequeira Trovao; Guy Baele; Eric van Wijngaerden; Anne Mieke Vandamme; Kristel van Laethem; Philippe Lemey;
PUBLISHED: 2016, SOURCE: VIRUSES-BASEL, VOLUME: 8, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
48
TITLE: HCV1b genome evolution under selective pressure of the cyclophilin inhibitor alisporivir during the DEB-025-HCV-203 phase II clinical trial  Full Text
AUTHORS: Lize Cuypers; Joke Snoeck; Lien Kerremans; Pieter Libin; Raf Crabbe; Sonia Van Dooren; Gregoire Vuagniaux; Anne Mieke Vandamme;
PUBLISHED: 2016, SOURCE: INFECTION GENETICS AND EVOLUTION, VOLUME: 44
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
49
TITLE: Detection of Natural Resistance-Associated Substitutions by Ion Semiconductor Technology in HCV1b Positive, Direct-Acting Antiviral Agents-Naive Patients  Full Text
AUTHORS: Marascio, N; Pavia, G; Strazzulla, A; Dierckx, T; Cuypers, L; Vrancken, B; Barreca, GS; Mirante, T; Malanga, D; Oliveira, DM; Vandamme, AM; Torti, C; Liberto, MC; Focà, A; Giancotti, A; Zicca, E; Costa, C; Pisani, V; Postorino, MC; Mazzitelli, M;
PUBLISHED: 2016, SOURCE: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, VOLUME: 17, ISSUE: 9
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
50
TITLE: Family Aggregation of Human T-Lymphotropic Virus 1-Associated Diseases: A Systematic Review
AUTHORS: Alvarez, C; Gotuzzo, E; Vandamme, AM; Verdonck, K;
PUBLISHED: 2016, SOURCE: FRONTIERS IN MICROBIOLOGY, VOLUME: 7, ISSUE: OCT
INDEXED IN: Scopus WOS CrossRef: 14
IN MY: ORCID
Page 5 of 45. Total results: 445.